Health Catalyst, Inc. (NASDAQ:HCAT) Stake Raised by Geode Capital Management LLC

Geode Capital Management LLC boosted its holdings in shares of Health Catalyst, Inc. (NASDAQ:HCAT) by 0.2% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,446,600 shares of the company’s stock after acquiring an additional 3,564 shares during the quarter. Geode Capital Management LLC’s holdings in Health Catalyst were worth $10,230,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently bought and sold shares of the business. Quantbot Technologies LP acquired a new stake in shares of Health Catalyst during the fourth quarter worth approximately $29,000. Stoneridge Investment Partners LLC purchased a new stake in Health Catalyst in the 4th quarter worth approximately $77,000. Virtu Financial LLC acquired a new stake in shares of Health Catalyst during the 4th quarter valued at $110,000. Dynamic Advisor Solutions LLC acquired a new stake in shares of Health Catalyst during the 4th quarter valued at $180,000. Finally, Avanza Fonder AB acquired a new position in shares of Health Catalyst in the fourth quarter worth $184,000. Hedge funds and other institutional investors own 85.00% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts recently issued reports on HCAT shares. Piper Sandler reduced their price objective on Health Catalyst from $12.00 to $8.00 and set an “overweight” rating for the company in a research report on Tuesday, February 11th. Canaccord Genuity Group reduced their price target on Health Catalyst from $11.00 to $10.00 and set a “buy” rating for the company in a report on Tuesday, January 21st. Citigroup dropped their price objective on Health Catalyst from $10.50 to $10.00 and set a “buy” rating on the stock in a report on Friday, January 10th. Stephens reduced their target price on shares of Health Catalyst from $7.00 to $5.00 and set an “equal weight” rating for the company in a research note on Thursday, March 6th. Finally, Evercore ISI lowered shares of Health Catalyst from an “outperform” rating to an “inline” rating in a research note on Wednesday, April 9th. Three research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, Health Catalyst presently has an average rating of “Moderate Buy” and a consensus price target of $8.36.

Health Catalyst Price Performance

Shares of Health Catalyst stock opened at $3.66 on Wednesday. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.32. The firm has a fifty day simple moving average of $4.39 and a 200-day simple moving average of $6.30. The stock has a market capitalization of $256.97 million, a price-to-earnings ratio of -2.71 and a beta of 1.43. Health Catalyst, Inc. has a 1-year low of $3.56 and a 1-year high of $9.24.

Insider Buying and Selling

In other Health Catalyst news, General Counsel Benjamin Landry sold 13,827 shares of the firm’s stock in a transaction that occurred on Thursday, March 6th. The stock was sold at an average price of $4.55, for a total value of $62,912.85. Following the sale, the general counsel now owns 160,437 shares of the company’s stock, valued at $729,988.35. This trade represents a 7.93 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, COO Daniel Lesueur sold 16,902 shares of Health Catalyst stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $4.52, for a total value of $76,397.04. Following the completion of the transaction, the chief operating officer now directly owns 216,250 shares in the company, valued at approximately $977,450. This represents a 7.25 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 47,588 shares of company stock worth $225,906 in the last quarter. 2.50% of the stock is currently owned by company insiders.

About Health Catalyst

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.